NASDAQ · Financial Statements
OnKure Therapeutics, Inc. (OKUR) Financial Statements
$2.31
NASDAQ: OKUR
Market Cap $93.52M
Overview Financials Dividend OnKure Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $-60.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-40.0M $-30.0M $-37.0M $-54.0M $-63.0M Net Profit $-40.0M $-30.0M $-35.0M $-53.0M $-60.0M EPS $-21.92 $-2.21 $-2.65 $-3.95 $-4.40 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $154.0M $16.0M $36.0M $115.0M $62.0M Total Liabilities $7.0M $70.0M $138.0M $11.0M $6.0M Cash $125.0M $12.0M $30.0M $111.0M $59.0M Borrowings $0 $1.0M $1.0M $1.0M $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-38.0M $-27.0M $-35.0M $-51.0M $-52.0M Investing Cash Flow $-24.0M $-2.0M $0 $16.0M $0 Financing Cash Flow $0 $-1.0M $-1.0M $51.0M $0 Net Cash Flow $71.0M $-2.0M $18.0M $81.0M $-52.0M Free Cash Flow $-38.0M $-28.0M $-35.0M $-51.0M $-52.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.02 EV / EBITDA 1.07 FCF Yield -46.17% Quick Ratio 26.75 Interest Coverage -7767.50 Return 1Y 68.73% Return 3Y -94.25% Return 5Y -95.21%
Screens featuring this stock